BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

All of the above-described awards were made under BridgeBio\xe2\x80\x99s 2019 Inducement Equity Plan (the Plan).\nThe above-described awards were each granted as an inducement material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4), and were granted pursuant to the terms of the Plan.